Name：Evaluation & analysis of medicinal in Chinese
Supervisory unit：China Medical Biotechnology Association
Organizer：China Medical Biotechnology Association & Chongqing University Cancer Hospital
Chairman of the Editorial Board：Du Guanhua
Chairman：Wu Yongzhong
Editor in Chief：Zhang Xianglin
Executive editor：Luo Rui
Publication：Evaluation & analysis of medicinal in Chinese Co.,Ltd
Cycle：Monthly
Address：Beijing
Language：Chinese
Size：16mo
Current Journal
Scan QR code to subscribe
Scan QR code to subscribe
About the Journal
-
Application of Intelligent Pharmaceutical Services in Outpatient Pharmaceutical Service Management
New
Author：XU Jing、 GONG Peng、 SONG Biao、 MENG Hongwu、 LI Yan、 LIU Jiatao、 SONG Bing2025-11 -
Current Status and Prospects of on Efficacy and Safety Evaluation of Insulin Biosimilars
New
Author：ZHAO Lingyi、 XING Xiaoxuan、 WANG Ke、 ZHANG Xiaotong、 WANG Zhizhou、 DONG Xianzhe、 ZHANG Lan2025-11
-
Progress of Anti-Tumour and Immunomodulatory Effects of Hedysarum Multijugum Maxim and Its Active Ingredients
New
Author：MENG Ziqi、 WANG Jingting、 SHANG Kun、 WANG Jing2025-11
-
Analysis of Adverse Drug Events Related to Semaglutide Injection (Weight-Loss Formulation) Based on the U. S. FAERS Database
New
Author：WANG Mengyang、 WANG Zhihong、 LI Xinyan、 MA Yinglin、 DONG Bin2025-11
-
Effect Analysis of Pharmaceutical Intervention Based on PDCA Model on Reducing the Antibiotics Use Intensity
New
Author：LI Yinghui、 REN Xiaohe、 LI Rong2025-11
-
Application Practice Effect of Prescription Pre-Review System in a Grade Ⅲ, Level A Traditional Chinese Medicine Hospital
New
Author：YANG Hui、 JIN Yan、 ZHOU Dexi、 FAN Zongbing、 XU Qiang2025-11
-
Analysis on Rationality of Benzodiazepine Receptor Agonists in a Grade Ⅲ, Level A Psychiatric Hospital
New
Author：HE Lian、 YUN Yuan、 LIU Changqing、 XIE Wanjun、 ZHANG Qian2025-11
-
Drug Selection Practice for Proprotein Convertase Subtilisin / Kexin Type 9 Inhibitors in Lipid-Lowering Therapy
New
Author：LI Congxin、 LI Xuejing、 YANG Jie、 QIU Bo、 QIE Suhui2025-11
-
Rapid Health Technology Assessment of Denosumab Versus Bisphosphonates in the Treatment of Osteoporosis
New
Author：FENG Xin、 LANG Xiaona、 LI Lu、 LIU Naiyi2025-11
-
Comprehensive Clinical Evaluation on Off-Label Use of Doxycycline in Children Under 8 Years Old
New
Author：LUO Yun、 LI Shoulin、 WU Wenya2025-11